YourWay Cannabis Brands Inc.

CNSX:YOUR Stock Report

Market Cap: CA$23.2m

YourWay Cannabis Brands Past Earnings Performance

Past criteria checks 3/6

YourWay Cannabis Brands has been growing earnings at an average annual rate of 21.1%, while the Pharmaceuticals industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 104.2% per year. YourWay Cannabis Brands's return on equity is 18.4%, and it has net margins of 4.5%.

Key information

21.1%

Earnings growth rate

77.9%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate104.2%
Return on equity18.4%
Net Margin4.5%
Last Earnings Update30 Sep 2021

Recent past performance updates

Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Sep 01
Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Recent updates

Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Sep 01
Robust Earnings May Not Tell The Whole Story For Hollister Biosciences (CSE:HOLL)

Hollister Biosciences (CSE:HOLL) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Dec 28
Hollister Biosciences (CSE:HOLL) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Revenue & Expenses Breakdown

How YourWay Cannabis Brands makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:YOUR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2167340
30 Jun 2162240
31 Mar 2153040
31 Dec 2031-440
30 Sep 2019-440
30 Jun 2010-330
31 Mar 202-420
31 Dec 191-210
31 Dec 180-100

Quality Earnings: YOUR has high quality earnings.

Growing Profit Margin: YOUR became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: YOUR has become profitable over the past 5 years, growing earnings by 21.1% per year.

Accelerating Growth: YOUR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: YOUR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).


Return on Equity

High ROE: YOUR's Return on Equity (18.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/08/07 03:14
End of Day Share Price 2022/05/10 00:00
Earnings2021/09/30
Annual Earnings2020/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

YourWay Cannabis Brands Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution